文献速递临床试验与 GCP流行病学与生物统计医学人工智能与信息学

临床决策支持系统用于基层高血压管理的有效性:实用性整群随机对照试验的研究方案

Effectiveness of a clinical decision support system for hypertension management in primary care: study protocol for a pragmatic cluster-randomized controlled trial.
PubMed 文献 · Trials · 2022-05-16

LIGHT试验是一项在中国94个基层医疗点开展的实用性四阶段整群随机试验,评价临床决策支持系统(CDSS)对高血压管理的有效性。主要结局为提供指南推荐治疗的随访比例。嵌套的LIGHT-ACD试验以患者为随机单位,比较不同初始单药或双药降压治疗对血压变化的影响。

要点

  • LIGHT试验在中国94个基层医疗点开展,评价CDSS对指南依从性的改善效果。
  • 主要结局为提供指南推荐治疗的高血压管理随访比例。
  • 嵌套LIGHT-ACD试验以患者为随机单位,比较不同初始降压方案对血压变化的影响。

核心结论

  • LIGHT试验将提供CDSS改善中国基层高血压管理指南依从性的有效性证据。
  • 嵌套LIGHT-ACD试验将提供该场景下不同初始降压方案对血压管理效果的数据。

研究设计与样本

  • LIGHT试验为实用性四阶段整群随机试验,在中国94个基层医疗点开展,每个城市阶段将站点随机分配至CDSS高血压管理或常规照护。
  • 患者在站点随机化后前3个月入组,随访9个月。
  • 主要结局为提供指南推荐治疗的高血压管理随访比例。
  • LIGHT-ACD试验为嵌套于CDSS内的试验,以患者为随机单位,随机接受不同初始单药或双药降压治疗,主要结局为血压变化。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Clinical decision support systems (CDSS) are low-cost, scalable tools with the potential to improve guideline-based antihypertensive treatment in primary care, but their effectiveness needs to be tested, especially in low- and middle-income countries such as China. METHODS: The Learning Implementation of Guideline-based decision support system for Hypertension Treatment (LIGHT) trial is a pragmatic, four-stage, cluster-randomized trial conducted in 94 primary care sites in China. For each city-based stage, sites are randomly assigned to either implementation of the CDSS for hypertension management (which guides doctors' treatment recommendations based on measured blood pressure and patient characteristics), or usual care. Patients are enrolled during the first 3 months after site randomization and followed for 9 months. The primary outcome is the proportion of hypertension management visits at which guideline-based treatment is provided. In a nested trial conducted within the CDSS, with the patient as the unit of randomization, the LIGHT-ACD trial, patients are randomized to receive different initial mono- or dual-antihypertensive therapy. The primary outcome of the LIGHT-ACD trial is the changes in blood pressure. DISCUSSION: The LIGHT trial will provide evidence on the effectiveness of a CDSS for improving guideline adherence for hypertension management in primary care in China. The nested trial, the LIGHT-ACD trial, will provide data on the effect of different initial antihypertensive regimens for blood pressure management in this setting. TRIAL REGISTRATION: ClinicalTrials.gov, identifier: LIGHT (NCT03636334) and LIGHT-ACD (NCT03587103). Registered on 3 July 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Song J, Wang X, Wang B, et al. Effectiveness of a clinical decision support system for hypertension management in primary care: study protocol for a pragmatic cluster-randomized controlled trial. Trials. 2022. PMID: 35578345. doi:10.1186/s13063-022-06374-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。